Vanguard Group’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,117,826
| Closed | -$3.32M | – | 4113 |
|
|
2016
Q3 | $3.32M | Sell |
1,117,826
-50,365
| -4% | -$150K | ﹤0.01% | 3185 |
|
|
2016
Q2 | $1.74M | Sell |
1,168,191
-522,573
| -31% | -$779K | ﹤0.01% | 3417 |
|
|
2016
Q1 | $6.26M | Sell |
1,690,764
-283,980
| -14% | -$1.05M | ﹤0.01% | 2842 |
|
|
2015
Q4 | $19.9M | Buy |
1,974,744
+86,965
| +5% | +$878K | ﹤0.01% | 2306 |
|
|
2015
Q3 | $25.7M | Buy |
1,887,779
+37,066
| +2% | +$504K | ﹤0.01% | 2179 |
|
|
2015
Q2 | $35.1M | Buy |
1,850,713
+56,441
| +3% | +$1.07M | ﹤0.01% | 2112 |
|
|
2015
Q1 | $47M | Buy |
1,794,272
+129,582
| +8% | +$3.39M | ﹤0.01% | 1944 |
|
|
2014
Q4 | $34.9M | Buy |
1,664,690
+9,560
| +0.6% | +$200K | ﹤0.01% | 2007 |
|
|
2014
Q3 | $55.2M | Buy |
1,655,130
+32,424
| +2% | +$1.08M | ﹤0.01% | 1740 |
|
|
2014
Q2 | $52.1M | Buy |
1,622,706
+28,750
| +2% | +$923K | ﹤0.01% | 1811 |
|
|
2014
Q1 | $73.5M | Buy |
1,593,956
+115,805
| +8% | +$5.34M | 0.01% | 1573 |
|
|
2013
Q4 | $105M | Buy |
1,478,151
+118,060
| +9% | +$8.38M | 0.01% | 1289 |
|
|
2013
Q3 | $117M | Buy |
1,360,091
+470,535
| +53% | +$40.3M | 0.01% | 1140 |
|
|
2013
Q2 | $56.3M | Buy |
+889,556
| New | +$56.3M | 0.01% | 1551 |
|